135 related articles for article (PubMed ID: 37792304)
1. Rare myeloperoxidase-negative rectangular inclusions in acute promyelocytic leukemia after induction therapy.
Yao Q; Chen P; Fu X
Pediatr Blood Cancer; 2023 Dec; 70(12):e30702. PubMed ID: 37792304
[No Abstract] [Full Text] [Related]
2. Acute promyelocytic leukaemia with myeloperoxidase-negative rectangular inclusions.
Mo X; Chen H
Br J Haematol; 2020 Jan; 188(1):8. PubMed ID: 31821543
[No Abstract] [Full Text] [Related]
3. [Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis].
Matsuda H; Misawa K; Ochiai T; Fujioka I; Iwasaki H; Iwao N; Koike M; Komatsu N
Rinsho Ketsueki; 2020; 61(10):1511-1513. PubMed ID: 33162450
[TBL] [Abstract][Full Text] [Related]
4. "Faggot" neutrophils in acute promyelocytic leukaemia with ongoing tretinoin therapy.
Ma S; Yang LH; Luedke C; Ingersoll K; Wang E
Br J Haematol; 2018 Oct; 183(2):169. PubMed ID: 29923183
[No Abstract] [Full Text] [Related]
5. Glomerulonephritis Secondary to Acute Promyelocytic Leukemia that Resolved after Induction Therapy.
Regino CA; Torres JD; Galvis CC; Cabrera HB; Sanz MÁ
Acta Haematol; 2023; 146(3):240-244. PubMed ID: 36538909
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia.
Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H
Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226
[No Abstract] [Full Text] [Related]
7. Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009.
Fisher BT; Singh S; Huang YS; Li Y; Gregory J; Walker D; Seif AE; Kavcic M; Aplenc R
Pediatr Blood Cancer; 2014 Jan; 61(1):68-73. PubMed ID: 23868668
[TBL] [Abstract][Full Text] [Related]
8. Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia.
Zhu HH; Huang XJ
N Engl J Med; 2014 Dec; 371(23):2239-41. PubMed ID: 25470713
[No Abstract] [Full Text] [Related]
9. [Treatment for acute promyelocytic leukemia].
Fujita H
Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
[No Abstract] [Full Text] [Related]
10. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)].
Franke M; Theurich S; Beyer F; Persigehl T
Rofo; 2014 Jun; 186(6):615-7. PubMed ID: 24347358
[No Abstract] [Full Text] [Related]
12. Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group.
Park KM; Yoo KH; Kim SK; Lee JW; Chung NG; Ju HY; Koo HH; Lyu CJ; Han SM; Han JW; Choi JY; Hong KT; Kang HJ; Shin HY; Im HJ; Koh KN; Kim H; Kook H; Baek HJ; Kim BR; Yang EJ; Lim JY; Park ES; Choi EJ; Park SK; Lee JM; Shim YJ; Kim JY; Park JK; Kong SG; Choi YB; Cho B; Lim YT
Cancer Res Treat; 2022 Jan; 54(1):269-276. PubMed ID: 33887821
[TBL] [Abstract][Full Text] [Related]
13. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
14. Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.
Aoki A; Yoneda N; Yoneda S; Miyazono T; Sugiyama T; Saito S
J Obstet Gynaecol Res; 2011 Nov; 37(11):1759-63. PubMed ID: 21790892
[TBL] [Abstract][Full Text] [Related]
15. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
Di Micco L; Mirenghi F; Morelli E; De Simone E
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
[TBL] [Abstract][Full Text] [Related]
16. Differentiation therapy for acute promyelocytic leukemia.
Fenaux P; Degos L
N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
[No Abstract] [Full Text] [Related]
17. All-trans retinoic acid 45 mg/m
Zhang X; Feng S; Xu J; Zhao N; Hu X; Zhou L; Tong J; Xue L; Zhang L; Han Y; Wang X; Geng L; Zhu X; Tang B; Liu H; Zhu W; Cai X; Liu X; Sun Z; Zheng C
Blood Cancer J; 2021 Jan; 11(1):15. PubMed ID: 33514684
[No Abstract] [Full Text] [Related]
18. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
19. Case report: Purulent transformation of granulocytic sarcoma: An unusual pattern of differentiation in acute promyelocytic leukemia.
Collinge E; Tigaud I; Balme B; Gerland LM; Sujobert P; Carlioz V; Salles G; Thomas X; Paubelle E
Medicine (Baltimore); 2018 Feb; 97(8):e9657. PubMed ID: 29465554
[TBL] [Abstract][Full Text] [Related]
20. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]